JPWO2022241215A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022241215A5
JPWO2022241215A5 JP2023570161A JP2023570161A JPWO2022241215A5 JP WO2022241215 A5 JPWO2022241215 A5 JP WO2022241215A5 JP 2023570161 A JP2023570161 A JP 2023570161A JP 2023570161 A JP2023570161 A JP 2023570161A JP WO2022241215 A5 JPWO2022241215 A5 JP WO2022241215A5
Authority
JP
Japan
Prior art keywords
helper plasmid
adenovirus helper
nucleotide sequence
seq
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570161A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518553A (ja
JP2024518553A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029193 external-priority patent/WO2022241215A2/en
Publication of JP2024518553A publication Critical patent/JP2024518553A/ja
Publication of JP2024518553A5 publication Critical patent/JP2024518553A5/ja
Publication of JPWO2022241215A5 publication Critical patent/JPWO2022241215A5/ja
Pending legal-status Critical Current

Links

JP2023570161A 2021-05-13 2022-05-13 アデノウイルスヘルパープラスミド Pending JP2024518553A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163188294P 2021-05-13 2021-05-13
US63/188,294 2021-05-13
PCT/US2022/029193 WO2022241215A2 (en) 2021-05-13 2022-05-13 Adenoviral helper plasmid

Publications (3)

Publication Number Publication Date
JP2024518553A JP2024518553A (ja) 2024-05-01
JP2024518553A5 JP2024518553A5 (https=) 2025-05-20
JPWO2022241215A5 true JPWO2022241215A5 (https=) 2025-05-20

Family

ID=84029842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570161A Pending JP2024518553A (ja) 2021-05-13 2022-05-13 アデノウイルスヘルパープラスミド

Country Status (9)

Country Link
US (1) US20250019667A1 (https=)
EP (1) EP4337236A4 (https=)
JP (1) JP2024518553A (https=)
KR (1) KR20240036508A (https=)
CN (1) CN117897167A (https=)
AU (1) AU2022272316A1 (https=)
CA (1) CA3218342A1 (https=)
IL (1) IL308472A (https=)
WO (1) WO2022241215A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4619018A2 (en) * 2022-11-16 2025-09-24 Forge Biologics, Inc. Adenoviral helper plasmid
CN119842820A (zh) * 2023-10-16 2025-04-18 深圳市深研生物科技有限公司 用于生产重组腺相关病毒载体的方法及包装/生产细胞

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223391A (en) * 1990-02-21 1993-06-29 President And Fellows Of Harvard College Inhibitors of herpes simplex virus replication
US5543264A (en) * 1990-06-29 1996-08-06 Associated Universities, Inc. Co-factor activated recombinant adenovirus proteinases
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
AU2001257611A1 (en) * 2000-04-28 2001-11-12 Avigen, Inc. Polynucleotides for use in recombinant adeno-associated virus virion production
US7754201B2 (en) * 2000-06-02 2010-07-13 GenPhar, Inc Method of vaccination through serotype rotation
EP2336339A3 (en) * 2000-09-25 2011-09-14 The Regents of the University of Michigan Production of viral vectors
US20040197347A1 (en) * 2002-09-23 2004-10-07 Board Of Regents, The University Of Texas System Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family
WO2004083418A1 (en) * 2003-03-17 2004-09-30 Merck & Co., Inc. Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
US20050118683A1 (en) * 2003-06-11 2005-06-02 Wood Clive R. Method for producing a polypeptide
US20080063656A1 (en) * 2004-08-09 2008-03-13 Emini Emilio A Adenoviral Vector Compositions
CN103436507B (zh) * 2006-05-05 2016-04-20 冈戈根股份有限公司 噬菌体衍生的抗微生物活性剂
EP2463362B1 (en) * 2007-11-28 2017-11-08 The Trustees Of The University Of Pennsylvania Simian subfamily c adenovirus SAdv-31 and uses thereof
WO2010115172A2 (en) * 2009-04-03 2010-10-07 University Of Washington Antigenic peptide of hsv-2 and methods for using same
US20120171191A1 (en) * 2009-05-26 2012-07-05 Cellectis Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
US20110293511A1 (en) * 2009-09-29 2011-12-01 Terrance Grant Johns Specific binding proteins and uses thereof
WO2018017925A1 (en) * 2016-07-22 2018-01-25 President And Fellows Of Harvard College Targeting lytic and latent herpes simplex virus 1 infection with crispr/cas9
KR102652494B1 (ko) * 2017-07-18 2024-03-28 제노비에 에이비 전장 t-세포 수용체 오픈 리딩 프레임의 신속한 조립 및 다양화를 위한 2-성분 벡터 라이브러리 시스템
US12370269B2 (en) * 2018-03-02 2025-07-29 University Of Florida Research Foundation, Incorporated Retinal protective factor 2 (RPF2) protein delivered by adeno-associated virus expression
EP3784785A4 (en) * 2018-04-23 2022-02-16 Duke University DOWNREGULATION OF SNCA EXPRESSION BY TARGETED EDITING OF DNA METHYLATION
US20210324415A1 (en) * 2018-10-09 2021-10-21 Nikegen, Llc Compositions and methods for preparing viral vectors
GB201816919D0 (en) * 2018-10-17 2018-11-28 Glaxosmithkline Ip Dev Ltd Adeno-associated viral vector producer cell lines
SG10201906637UA (en) * 2019-07-17 2021-02-25 Agency Science Tech & Res Treatment/prevention of disease by linc complex inhibition
CN114761030A (zh) * 2019-11-01 2022-07-15 休斯敦系统大学 具有诱导的抗肿瘤免疫的溶瘤病毒疗法
US11130787B2 (en) * 2020-06-11 2021-09-28 MBF Therapeutics, Inc. Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods

Similar Documents

Publication Publication Date Title
JPWO2020086881A5 (https=)
US12104175B2 (en) High activity regulatory elements
JP2020537544A5 (https=)
JP2022078208A5 (https=)
CA2366861A1 (en) Compositions and methods for helper-free production of recombinant adeno-associated viruses
CA2985372C (en) Polynucleotides, vectors and methods for insertion and expression of transgenes
CA2222140A1 (en) Packaging systems for human recombinant adenovirus to be used in gene therapy
JPWO2020223231A5 (https=)
JPWO2020223236A5 (https=)
WO2024217518A1 (zh) 核酸分子及其作为启动子的应用
KR20250135175A (ko) 아데노바이러스 헬퍼 플라스미드
JPWO2021188729A5 (https=)
US20250019667A1 (en) Adenoviral helper plasmid
JPWO2022241215A5 (https=)
Souza et al. Novel cloning method for recombinant adenovirus construction in Escherichia coli
JPWO2019186274A5 (https=)
Li et al. Construction of phospholamban antisense RNA recombinant adeno‐associated virus vector and its effects in rat cardiomyocytes 1
WO2025262205A1 (en) Nucleic acid sequences
WO2025262203A1 (en) Nucleic acid sequences
JPWO2020219766A5 (https=)
JPWO2023060113A5 (https=)
JPWO2020219726A5 (https=)
JPWO2023220502A5 (https=)
KR20260052122A (ko) 아데노-연관 바이러스(AAV) 기반 벡터의 생산을 위한 아데노바이러스 E2a 유전자의 변형된 서열 (변이체)
TW202506203A (zh) 用於產生根據腺相關病毒(AAV)之載體的腺病毒E2a基因的經修飾之序列(變體)